LOSS OF BAP1 CONFERS RESISTANCE TO FERROPTOSIS AND PROMOTES CHOLANGIOCARCINOMA DEVELOPMENT

被引：0
|
作者：
Classon, Peyton [1 ]
Jaramillo, Sophia [1 ]
Carlson, Danielle [1 ]
Yan, Irene [2 ]
Ilyas, Sumera [1 ]
Smoot, Rory [1 ]
Gores, Gregory [1 ]
Patel, Tushar
Povero, Davide [1 ]
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Mayo Clin Florida, Jacksonville, FL USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1830
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The role of BAP1 loss of function in uveal melanoma
    Brooks, K.
    Dhomen, N.
    Marais, R.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S60 - S61
  • [22] BAP1 Loss in Triple Negative Breast Cancer
    Vougiouklakis, Theodore
    Schwartz, Christopher
    Cotzia, Paolo
    Snuderl, Matija
    Jour, George
    Darvishian, Farbod
    LABORATORY INVESTIGATION, 2019, 99
  • [23] Prognostic role of BAP1 and PBRM1 expression in intrahepatic cholangiocarcinoma
    Sarcognato, S.
    Gringeri, E.
    Fassan, M.
    Di Giunta, M.
    Guzzardo, V.
    Cillo, U.
    Guido, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 39 - 39
  • [24] Use of Mutational Analysis and BAP1 Immunohistochemistry for Diagnosis of Intrahepatic Cholangiocarcinoma
    Molden, Brent
    Joseph, Nancy
    Mattis, Aras
    Mattis, Daiva
    Kakar, Sanjay
    MODERN PATHOLOGY, 2018, 31 : 642 - 643
  • [25] BAP1 Loss in Triple Negative Breast Cancer
    Vougiouklakis, Theodore
    Schwartz, Christopher
    Cotzia, Paolo
    Snuderl, Matija
    Jour, George
    Darvishian, Farbod
    MODERN PATHOLOGY, 2019, 32
  • [26] Use of Mutational Analysis and BAP1 Immunohistochemistry for Diagnosis of Intrahepatic Cholangiocarcinoma
    Molden, Brent
    Joseph, Nancy
    Mattis, Aras
    Mattis, Daiva
    Kakar, Sanjay
    LABORATORY INVESTIGATION, 2018, 98 : 642 - 643
  • [27] Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinoma
    Mosbeh, Asmaa
    Halfawy, Khalil
    Abdel-Mageed, Wael S.
    Sweed, Dina
    Rahman, Mohamed H. Abdel
    CANCER GENETICS, 2018, 224 : 21 - 28
  • [28] BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression
    Zhang, Yilei
    Zhuang, Li
    Gan, Boyi
    MOLECULAR & CELLULAR ONCOLOGY, 2019, 6 (01):
  • [29] Loss of BAP1 Leads to More YAPing in Pancreatic Cancer
    Brekken, Rolf A.
    CANCER RESEARCH, 2020, 80 (08) : 1624 - 1625
  • [30] Loss of expression of BAP1 predicts longer survival in mesothelioma
    Farzin, Mahtab
    Toon, Christopher W.
    Clarkson, Adele
    Sioson, Loretta
    Watson, Nicole
    Andrici, Juliana
    Gill, Anthony J.
    PATHOLOGY, 2015, 47 (04) : 302 - 307
12345